Rafarma Approves Issuance of Majority of Voting Shares to Board Chairman Ilya Shpurov Ljubljana, Slovenia, Oct. 06, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce approval of Ilya Shpurov receiving the majority of Preferred B shares,...

Rafarma - Biocogency Acquisition Progresses to Preparation of GAAP Financials and Form 10 Drafting for Full SEC Reporting Ljubljana, Slovenia, Aug. 14, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to update its shareholders on the progress of its acquisition by the R. & D. BIOCOGENCY...